-- 
Befimmo, DSM, Nyrstar, Vopak: Benelux Equity Market Preview

-- B y   J o h n   M a r t e n s   a n d   F r e d   P a l s
-- 
2011-04-27T04:00:01Z

-- http://www.bloomberg.com/news/2011-04-26/befimmo-dsm-nyrstar-vopak-benelux-equity-market-preview.html
The following companies may have
unusual price changes in Benelux markets. Stock symbols are in
parentheses, and prices are from the previous close.  The  AEX-Index (AEX)  in Amsterdam advanced 0.54, or 0.2 percent,
to 359.55.  Belgium ’s Bel20 Index rose 20.55, or 0.8 percent, to
2,748.22. Luxembourg’s LuxX Index fell 0.2 percent to 1,412.56.  Dutch stocks:  CSM (CSM)  NV: The world’s largest maker of bakery
ingredients may report first-quarter sales of 725 million euros
($1.06 billion), according to the average estimate of three
analysts surveyed by Bloomberg. CSM dropped 0.4 percent to 25.81
euros.  Royal DSM NV (DSM NA): The world’s largest vitamin maker
may report first-quarter net income of 127 million euros,
according to the average estimate of four analysts surveyed by
Bloomberg. DSM dropped 0.2 percent to 43.42 euros.  Royal Vopak NV (VPK NA): The world’s biggest chemical and
oil storage company is scheduled to give a first-quarter trading
update. Vopak retreated 0.1 percent to 33.35 euros.  Belgian stocks:  Befimmo SCA (BEFB BB): Belgium’s second-biggest real-estate
investment fund said it sold 162 million euros of 4.5 percent
six-year bonds in a public offering to individual investors.
Befimmo increased 0.8 percent to 61.47 euros.  Nyrstar (NYR)  NV: The world’s largest zinc producer
gives a first-quarter trading update before the start of
trading. Nyrstar dropped 0.3 percent to 9.59 euros.  PinguinLutosa (PIN)  NV:  Europe ’s second-largest producer
of frozen vegetables said first-quarter sales increased 4.5
percent to 118.6 million euros. PinguinLutosa gained 0.9 percent
to 10.24 euros.  To contact the reporters on this story:
John Martens in Brussels at 
 jmartens1@bloomberg.net ;
Fred Pals in Amsterdam at 
 fpals@bloomberg.net   To contact the editors responsible for this story:
Angela Cullen at   acullen8@bloomberg.net ;
Andrew Rummer at   arummer@bloomberg.net . 